Successful treatment of Candida glabrata myocarditis with voriconazole

Scandinavian Journal of Infectious Diseases

Volumn 34, Issue 10, 2002, Pages 778-780

  Einarsdóttir, Hilda M ^a   Danielsen, Ragnar ^a   Gottfredson, Magnús ^a  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B LIPID COMPLEX; FLUCONAZOLE; FLUCYTOSINE; VORICONAZOLE;

ABDOMINAL ABSCESS; ADULT; ARTICLE; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDA GLABRATA; CASE REPORT; CROHN DISEASE; DRUG WITHDRAWAL; FEVER; FUNGEMIA; FUNGUS ISOLATION; HEART ABSCESS; HEART PAPILLARY MUSCLE; HEART VENTRICLE SEPTUM; HOSPITAL DISCHARGE; HUMAN; INTESTINE RESECTION; MALE; MYOCARDITIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

ADULT; ANTIFUNGAL AGENTS; CANDIDA GLABRATA; CANDIDIASIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FOLLOW-UP STUDIES; FUNGEMIA; HUMANS; MALE; MYOCARDITIS; PYRIMIDINES; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TRIAZOLES;

EID: 0036440932     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540260348635     Document Type: Article

References (9)

1. Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995; 20: 1526-30.
2. Gumbo T, Isada CM, Hall G, Karafa MT, Gordon SM. Candida glabrata fungemia. Clinical features of 139 patients. Medicine (Baltimore) 1999; 78: 220-7.
3. Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W. Fungal endocarditis: evidence in the world literature, 1965-1995. Clin Infect Dis 2001; 32: 50-62.
4. Donal E, Abgueguen P, Coisne D, Gouello JP, McFadden EP, Allal J, et al. Echocardiographic features of Candida species endocarditis: 12 cases and a review of published reports. Heart 2001; 86: 179-82.
5. Atkinson JB, Connor DH, Robinowitz M, McAllister HA, Virmani R. Cardiac fungal infections: review of autopsy findings in 60 patients. Hum Pathol 1984; 15: 935-42.
6. NCCLS. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard. Document M-27A. Wayne, PA: NCCLS, 1997.
7. Pfaller MA, Diekema DJ, Jones RN, Sader HS, Fluit AC, Hollis RJ, et al. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program. J Clin Microbiol 2001; 39: 3254-9.
8. Kronvall G, Karlsson I. Fluconazole and voriconazole multidisk testing of Candida species for disk test calibration and MIC estimation. J Clin Microbiol 2001; 39: 1422-8.
9. Martin MV, Yates J, Hitchcock CA. Comparison of voriconazole (UK-109,496) and itraconazole in prevention and treatment of Aspergillus fumigatus endocarditis in guinea pigs. Antimicrob Agents Chemother 1997; 41: 13-6.